Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.682 USD | -3.40% | +6.58% | -10.26% |
Chart calendar Phio Pharmaceuticals Corp.
Upcoming events on Phio Pharmaceuticals Corp.
Past events on Phio Pharmaceuticals Corp.
2024-04-02 07:30 am | Q4 2023 Earnings Release |
2024-03-22 01:00 pm | Immunotherapy of Cancer Conference |
2024-03-21 01:00 pm | Immunotherapy of Cancer Conference |
2024-03-21 01:00 pm | Immunotherapy of Cancer Conference - Poster No : P01.03 |
2023-11-09 04:30 pm | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Release |
2023-07-20 09:00 am | Annual General Meeting |
2023-05-17 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
2023-05-11 05:00 pm | Q1 2023 Earnings Release |
2023-04-18 01:30 pm | American Association for Cancer Research Meeting |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Intratumoral PH-762 |
2023-03-22 05:05 pm | Q4 2022 Earnings Release |
2023-01-25 | Reverse Split: 1 of 12 |
2023-01-07 | Dermatology Summit |
2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract #: 1402 |
2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract #:788 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -10,8 -12,0 9.8% | -13,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -13,4 |
Net income Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -13,4 |
EPS USD | Released Forecast Spread | -232 -224 -3.37% | -23,0 -23,0 0% | -12,5 -13,3 6.31% | -10,1 -10,9 7.51% | -5,20 -6,26 16.93% | -3,56 |
Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
EBIT Million USD | Released Forecast Spread | -3,45 -4,40 21.59% | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -1,90 -3,10 38.74% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | |
Net income Million USD | Released Forecast Spread | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% |
EPS USD | Released Forecast Spread | -3,12 -3,84 18.75% | -2,28 -3,60 36.67% | -2,28 -3,72 38.71% | -3,12 4,32 -172.22% | -2,42 -3,24 25.31% | -1,47 | -1,14 -1,43 20.28% | -0,17 -1,30 86.92% |
Announcement Date | 22/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 |
Past sector events for Phio Pharmaceuticals Corp.
Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHIO Stock
- Calendar Phio Pharmaceuticals Corp.